Richards Christos 4
4 · Coherus BioSciences, Inc. · Filed Feb 5, 2018
Insider Transaction Report
Form 4
Richards Christos
Director
Transactions
- Award
Stock Option (Right to Buy)
2018-02-01+20,000→ 20,000 totalExercise: $10.05Exp: 2028-02-01→ Common Stock (20,000 underlying)
Holdings
- 63,836
Common Stock, $0.0001 par value
Footnotes (1)
- [F1]The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from February 1, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.